Renal AL Amyloid Involvement and NEOD001 (RAIN)
The RAIN Study, a Multicenter Randomized Double-blind Phase 2b Study of NEOD001 in Previously Treated Subjects With Systemic Light-chain (AL) Amyloidosis and Persistent Renal Involvement
Sponsor: Tufts Medical Center
Terminated
Futility
This PHASE2 trial investigates Amyloidosis and is currently terminated or withdrawn. Tufts Medical Center leads this study, which shows 10 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Oct 2020 — Jan 2021 [monthly]
Terminated PHASE2
-
Jan 2020 — Oct 2020 [monthly]
Terminated PHASE2
▶ Show 5 earlier versions
-
Aug 2019 — Jan 2020 [monthly]
Terminated PHASE2
Status: Active Not Recruiting → Terminated
-
Jun 2018 — Aug 2019 [monthly]
Active Not Recruiting PHASE2
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Aug 2017 — May 2018 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Jul 2017 — Aug 2017 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Tufts Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .